Creating Human Lab Rats For Cancer Research: Part II
Were Vaccines Indeed the Hidden Source of a Laboratory-Produced Contagious
Cancer Virus Epidemic?
The beginning of the AIDS/cancer epidemic (1978) coincides
with experimental hepatitis vaccine given internationally to homosexuals (2nd
graph below):
Mortality Ratio
begins sudden rise in New York homosexuals the same year as experimental
vaccine study conducted in that city (just before AIDS began):
“Studies of hepatitis B virus infection among
homosexual men provide the opportunity to study mortality trends in a large
cohort of homosexual men who were first seen just before the AIDS epidemic
was recognized.” [emphasis added]
“In
obliterating one disease, another was transformed.”
In addition to providing a model form of viral human cancer
for vaccine research through selective immune cell depopulation:
“The AIDS-malignancies have
provided insights into the pathogenesis of neoplastic disease in general and
into strategies for further therapeutic intervention.”[1]
…the selective international depopulation effects of
HIV are fulfilling national security goals outlined in a 200-page classified
NSC memo prior to AIDS:
Population control linked to third world
resources:
“…the US economy will
require large and increasing amounts of minerals from abroad; especially from
less developed countries…Wherever a lessening of population pressures through
reduced birth rates can increase the prospects for such stability, population
policy becomes relevant to resource supplies and to the economic interests of
the United States.” [emphasis added]
No easy solutions seen for the
planners:
“... short of Draconian
measures there is no possibility that any LDC [Less Developed Country] can
stabilize its population at less than double its present size. For many,
stabilization will not be short of three times their present size.”[2]
The Predictable Results:
AIDS
and Population Control: “Draconian Measures”?
The
depopulation effect of AIDS is fulfilling national security goals for the Third
World, where 90% of AIDS deaths occur and where 95% of world population growth
occurs, that were outlined in classified national security planning documents
shortly before AIDS broke out. The AIDS epidemic is especially pronounced in
Africa, “the continent with the world’s fastest-expanding population.”[3]
(Eastern and southern Africa, which have only 5% of the world’s population,
account for 60% of all AIDS deaths.[4])
Indeed, the
AIDS disaster has conveniently begun to fulfill the goals for population reduction
in third world areas such as Africa:
“Some officials in
government already privately contend that family planning is not as necessary
in Africa because AIDS will take care of the rapid growth in the population.” [5]
AIDS
and Cancer Research
“As disastrous as the spread
of HIV is, the insights that the AIDS epidemic provides into the causes of
cancer may ultimately lead to new and successful approaches to cancer
prevention.” [6]
In addition to serving as
a population control function, the epidemic of AIDS-related sarcomas and other
cancers is providing a near ideal research model to study “host defenses” to
human cancer similar to that developed through Chester
Southam’s cancer injection experiments. In fact, long before AIDS, Southam
himself predicted the experimental benefits that such “immunologic disorders”
might hold for cancer vaccine research:
“In addition to the need for
more definitive studies in man, these studies suggest … that the relation of host
defenses to the course of human cancer might be studied fruitfully in
patients with immunologic disorders such as lymphocytic leukemia, allergy
and ‘autoimmune’ diseases".[7]
[emphasis added]
AIDS is providing an
international supply of humans developing convenient cancers as “immunologic
disorders” take effect under the watchful eyes of researchers.
Ongoing research has shown that
HIV—by allowing researchers to monitor cancer growth and correlate it with
virus exposure as AIDS victims’ immune systems selectively degrade—is providing
a tremendous amount of knowledge of the human immune response to cancer viruses
which will likely lead to the coveted development of human cancer vaccines.[8]
These developments make the
AIDS epidemic uniquely suited to the long-range goal of developing human cancer
vaccines.[9]
In fact, based on the latest animal research in which modified forms of HIV
were used not only to cause cancer, but to cure it, the HIV itself may
eventually be used as a human cancer vaccine!
Thus, it seems as if, at least
for cancer vaccine research and national security-related depopulationist
goals, that AIDS is “the
‘perfect’ disease”.
* * *
Based on the documented history
of cancer vaccine researchers deliberately inducing cancer in humans and the
striking developments in the AIDS monkey virus-related cancer epidemic noted
above, it seems reasonable to ask:
Are these convenient results
due to the culmination of the precedent-setting cancer vaccine research
in which monkey cancer viruses were injected in human subjects applied
to ever expanding groups of people used as cancer research lab rats?
Unfortunately,
·
there is no doubt that
cancer researchers had immunosuppressive monkey viruses like AIDS prior to the
human AIDS epidemic--experiments to develop and test them were published in the
medical literature.
·
there is no doubt that
cancer researchers had exploited immunosuppression to deliberately induce human
sarcoma tumors with monkey cancer viruses--human experiments with these viruses
were published in the medical literature.
·
there is also no doubt
that the explosion of immunosuppression and sarcoma tumors in human AIDS
patients are proving to be highly beneficial to cancer researchers.
The only question is whether
these benefits are the result of cancer researchers continuing with the
procedures they had used prior to AIDS. We know the immunosuppressive monkey
viruses they had tested in human cells were combined with the monkey cancer
viruses they had already used in human experiments. Were follow-up human experiments conducted with these mixtures
and could this explain the explosion of human immunosuppression and cancer
which have been correlated to monkey viruses which somehow suddenly jumped the species
barrier?
Given:
·
the benefits of the
disease to cancer vaccine research
·
the similarities between
the AIDS virus and experimental cancer viruses which existed at the outset of
the epidemic and
·
the published history of
human experimentation with cancer-inducing injections
this unfortunate scenario seems all too likely.
Indeed, it seems highly improbable
that, by sheer chance, an unprecedented epidemic due to a type of virus
invented by cancer researchers began benefiting cancer researchers almost
immediately after they grew it in human cell cultures. More likely, the AIDS
epidemic was started as the continuation of a published line of human
experimentation with monkey cancer viruses which was designed to prove exactly
what AIDS has—that viruses cause human cancers; that the immune system is
capable of preventing these viral cancers and that therefore human cancer
vaccines are realizable.
Further Reading:
Next Page: Chester Southam Injects West
Nile Virus in Humans
Return to:
What You Should Know About the Anthrax and
Smallpox Vaccines
The Incestuous Ties Between the US Government and
Bin Laden
[1] M. Levine, “AIDS-Related
Malignancies: the Emerging Epidemic,” Journal of the National Cancer
Institute, vol. 85, no. 17, September 1, 1993, p. 1392.
[2] National Security Study Memorandum 200, December, 10, 1974
[3] AP, “Report Expects AIDS to Depress Africa’s Fast Population Growth,” New York Times, 7/3/96.
[4] AP, “Facts About AIDS in Africa,” Filed at 11:26 a.m. EST, By The Associated Press January 10, 2000.
[5] Jane Perlez, “AIDS in Africa Is Seen Halting Population Rise,” New York Times, 6/22/92.
[6] V. Beral, H. Jaffe, and R. Weiss, “Cancer Surveys: Cancer, HIV and AIDS,” Eur. J. Cancer, vol. 27, no. 8, 1991, 1058.
[7] Chester Southam, Alexander Brunschwig, Arthur Levin, Quirino Dizon, "Effect of Leukocytes on Transplantability of Human Cancer," Cancer, vol. 19 no. 1, November 1966, pp. 1743-1753.
[8] Indeed HIV is providing long-sought proof of the viral and immunodeficiency theories of cancer growth to vaccine researchers who not only invented immunosuppressive and cancer viruses for this very reason—but modified them for growth in human cells. The AIDS-induced cancer epidemic is also providing long-awaited evidence that the very cancer virus vaccine researchers had proposed (and grown in human cell cultures) as a cause of human cancer is indeed an agent in human cancer. This is one of the first steps required for a vaccine against viral forms of human cancer to be developed. Chester Southam, the cancer vaccine researcher who transplanted tumors in hundreds of human subjects, had written a decade before AIDS: “If and when a causative virus of human cancers is found, it may provide a source of antigen for cancer prophylaxis, but this is merely a hope for the future.” C. M. Southam, “Studies of Host Defense Against Human Cancer,” Indian J Cancer, vol. 4, no. 1, March 1967, 3-15.
[9] One group of cancer researchers summarized: “As disastrous as the spread of HIV is, the insights that the AIDS epidemic provides into the causes of cancer may ultimately lead to new and successful approaches to cancer prevention.” V. Beral, H. Jaffe, and R. Weiss, “Cancer Surveys: Cancer, HIV and AIDS,” Eur. J. Cancer, vol. 27, no. 8, 1991, 1058.